RIVERVEST VENTURE FUND III, L.P. enters ONKURE THERAPEUTICS, INC. with 279.34K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Indirect Derivatives
Filed: 4/8/2021ACC: 0000899243-21-015406
10% Owner
Since Apr 2021
279.34K
Baseline shares
0.00
Direct ownership
0 positions
1.93M
Derivative underlying
2 instruments
1
Security positions
279.34K indirect
Non-Derivative Holdings1
Common Stock
IndirectShares owned279.34K
Total
279.34K indirect279.34K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 279.34K | Indirect |
| Total | 279.34K | 279.34K indirect |
Derivative Holdings2
Series B Preferred Stock
IndirectUnderlying security
Common Stock
Underlying shares
829.11K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Series A Preferred Stock
IndirectUnderlying security
Common Stock
Underlying shares
1.10M
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Total
Underlying
1.93M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Series B Preferred Stock Indirect | Common Stock | — | — | 829.11K | N/A | |
| Series A Preferred Stock Indirect | Common Stock | — | — | 1.10M | N/A | |
| Total | 1.93M | 0.00 | ||||